Clarus Wealth Advisors Abb Vie Inc. Transaction History

Clarus Wealth Advisors

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 22, 2024	BUY	$137.6 - $154.97 $182,732 - $205,800	1,328 New	1,328 $205,000
Q4 2022 Jan 12, 2023	SELL	$138.31 - $165.87 $36,513 - $43,789	-264 Reduced 17.25%	1,266 $0
Q3 2022 Oct 11, 2022	BUY	$134.21 - $153.93 $205,341 - $235,512	1,530 New	1,530 $212,000
Q2 2022 Jul 13, 2022	SELL	$137.62 - $174.96 $171,474 - $218,000	-1,246 Closed	0 $0
Q1 2022 Apr 12, 2022	BUY	$131.98 - $163.75 $164,447 - $204,032	1,246 New	1,246 $212,000
Q3 2020 Oct 08, 2020	SELL	$85.91 - $100.83 $293,640 - $344,636	-3,418 Closed	0 $0
Q2 2020 Jul 09, 2020	BUY	$73.37 - $98.18 $14,674 - $19,636	200 Added 6.22%	3,418 $335,000
Q1 2020 Apr 08, 2020	BUY	$64.5 - $97.79 $207,561 - $314,688	3,218 New	3,218 $236,000
Q3 2019 Oct 11, 2019	SELL	$62.98 - $75.72 $110,718 - $133,115	-1,758 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$65.7 - $83.98 $985 - $1,259	15 Added 0.86%	1,758 $128,000
Q1 2019 Apr 04, 2019	SELL	$77.14 - $90.79 $539 - $635	-7 Reduced 0.4%	1,743 $140,000
Q4 2018 Feb 05, 2019	BUY	$77.85 - $96.01 $1,401 - $1,728	18 Added 1.04%	1,750 $161,000
Q4 2018 Jan 08, 2019	BUY	$77.85 - $96.01 $134,836 - $166,289	1,732 New	1,732 $164,000
Q4 2018 Jan 07, 2019	SELL	$77.85 - $96.01 $134,836 - $166,289	-1,732 Closed	0 $0
Q3 2018 Oct 03, 2018	SELL	$88.91 - $98.84 $81,263 - $90,339	-914 Reduced 34.54%	1,732 $164,000
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $297,928 - $398,953	-3,238 Reduced 55.03%	2,646 $250,000
Q4 2017 Feb 05, 2018	BUY	$89.56 - $98.21 $526,971 - $577,867	5,884	5,884 $569,000

3,943

1.26B

16.8M

12.1M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.